Journal of Pharmaceutics and Therapeutics
Vol. 6 No. 1 (2020)
Case Report

Resolution of Chemotherapy-Induced Peripheral Neuropathy with Subanesthetic Ketamine: A Case Report

PDF
  • Khan M,
  • Nguyen M,
  • Kerulis M,
  • Bal N,
  • Prabhneet P,
  • Irv W
Khan M
Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA
Nguyen M
Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA
Kerulis M
The Family Institute at Northwestern University, Evanston, IL, USA
Bal N
Ketamine Centers of Chicago, Chicago, IL, USA
Prabhneet P
Aureus University School of Medicine, Oranjestad, Aruba
Irv W
Ketamine Centers of Chicago, Chicago, IL, USA
DOI: https://doi.org/10.18314/jpt.v6i1.2034
Published August 12, 2020
Keywords
  • Chemotherapy,
  • Neuropathy,
  • Ketamine

Copyright (c) 2020 Khan et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Chemotherapeutic drugs have been shown to induce peripheral neuropathy which can become very painful, diminish functional ability, and decrease quality of life. Although Chemotherapy-Induced Peripheral Neuropathy (CIPN) may resolve completely in some individuals, others demonstrate partial or no resolution of symptoms. Presented is a case in which a female patient with a 2-year history of severe CIPN following the diagnosis and treatment of stage 3 triple negative BRCA 1 breast cancer was able to attain complete resolution of her symptoms after the use of subanesthetic ketamine.

PDF